FTFinancial Times·1hHealth
score-0.60
FDA Panel Advances Broader Public Access to 'Wolverine Peptide,' Incorporating Scientist Safety Concerns Into Review Process
Original
FDA panel supports access to peptides over scientist objections
“Headline emphasizes scientist objections and risk warnings while downplaying regulatory approval, creating concern-focused framing.”